CRMD - CorMedix, Inc.
0.60 0.00 (0.00%)
After hours: 5:22PM EDT
| Previous Close | 0.62 |
| Open | 0.63 |
| Bid | 0.60 x 9000 |
| Ask | 0.62 x 2000 |
| Day's Range | 0.59 - 0.63 |
| 52 Week Range | 0.32 - 2.48 |
| Volume | 988,696 |
| Avg. Volume | 1,296,052 |
| Market Cap | 36.97M |
| Beta | 2.38 |
| PE Ratio (TTM) | -0.92 |
| EPS (TTM) | -0.65 |
| Earnings Date | May 4, 2017 - May 8, 2017 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 4.00 |
- Capital Cube•7 days ago
ETFs with exposure to CorMedix, Inc. : October 12, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to CorMedix, Inc. Here are 5 ETFs with the largest exposure to CRMD-US. Comparing the performance and risk of CorMedix, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)
- Simply Wall St.•8 days ago
Is There Now An Opportunity In CorMedix Inc (CRMD)?
CorMedix Inc (AMEX:CRMD), a pharmaceuticals company based in United States, received a lot of attention from a substantial price increase on the AMEX in the over the last few months.Read More...
- ACCESSWIRE•21 days ago
CorMedix Inc. to Present at The MicroCap Conference
BEDMINSTER, NJ / ACCESSWIRE / September 28, 2017 / CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and ...
- ACCESSWIRE•24 days ago
CorMedix Inc. Relocates Corporate Headquarters
BERKELEY HEIGHTS, NJ / ACCESSWIRE / September 25, 2017 / CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention ...
- ACCESSWIRE•28 days ago
CorMedix Inc. to Present at The MicroCap Conference on October 5th in New York City at the Essex House
NEW YORK, NY / ACCESSWIRE / September 21, 2017 / CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment ...
- ACCESSWIRE•last month
CorMedix Inc. to Present at the Anti-Infectives Rx Conference
BEDMINSTER, NJ / ACCESSWIRE / September 12, 2017 / CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and ...
- ACCESSWIRE•last month
CorMedix Inc. Presents Data Demonstrating Antimicrobial Activity of Taurolidine Against Potentially Deadly Fungal Pathogen Candida auris
Poster Presented at the ASM/ESCMID Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance BEDMINSTER, NJ / ACCESSWIRE / September 7, 2017 / CorMedix Inc. (NYSE American: CRMD), ...
- Zacks•last month
Are Options Traders Betting on a Big Move in CorMedix (CRMD) Stock?
Investors in CorMedix (CRMD) need to pay close attention to the stock based on moves in the options market lately.
- ACCESSWIRE•last month
CorMedix Inc. to Present at 2017 Rodman & Renshaw 19th Annual Global Investment Conference
BEDMINSTER, NJ / ACCESSWIRE / September 5, 2017 / CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and ...
- Capital Cube•2 months ago
ETFs with exposure to CorMedix, Inc. : August 31, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to CorMedix, Inc. Here are 5 ETFs with the largest exposure to CRMD-US. Comparing the performance and risk of CorMedix, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)
- ACCESSWIRE•2 months ago
CorMedix Inc. Announces a Change to its Senior Leadership
BEDMINSTER, NJ / ACCESSWIRE / August 25, 2017 / CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment ...
Capital Cube•2 months agoCorMedix, Inc. :CRMD-US: Earnings Analysis: Q2, 2017 By the Numbers : August 24, 2017
Categories: Yahoo FinanceGet free summary analysis CorMedix, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of CorMedix, Inc. – Becton, Dickinson and Company, Emergent BioSolutions Inc., Utah Medical Products, Inc., Tetraphase Pharmaceuticals, Inc. and Achaogen, Inc. (BDX-US, EBS-US, UTMD-US, TTPH-US and AKAO-US) that have also ... Read more (Read more...)
- ACCESSWIRE•2 months ago
CorMedix, Inc. Awarded NIH Grant to Develop Advanced Antimicrobial Hydrogels for the Treatment and Prevention of Potentially Life-Threatening Infections in Severe Burns
BEDMINSTER, NJ / ACCESSWIRE / August 17, 2017 / CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment ...
- Zacks•2 months ago
Is the Options Market Predicting a Spike in CorMedix (CRMD) Stock?
Investors in CorMedix (CRMD) need to pay close attention to the stock based on moves in the options market lately.
- ACCESSWIRE•2 months ago
CorMedix Inc. Reports Second Quarter Financial Results and Provides Business Update
Conference Call Scheduled for Today at 4:30 p.m. Eastern Time Recent Corporate and Clinical Highlights : Implemented several key FDA-agreed changes to the LOCK-IT-100 trial designed to enhance event capture ...
- ACCESSWIRE•2 months ago
Investor Network: CorMedix Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / August 9, 2017 / CorMedix Inc. (NYSE American: CRMD ) will be discussing their earnings results in their Q2 Earnings Call to be held on Wednesday, August 9, 2017 at 4:30 PM ...
- ACCESSWIRE•2 months ago
CorMedix Inc. Appoints Gary Gelbfish, M.D., to Board of Directors
Current Director Myron Kaplan Elected Chairman of the Board BEDMINSTER, NJ / ACCESSWIRE / August 7, 2017 / CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing ...
- ACCESSWIRE•2 months ago
CorMedix Inc. to Report Second Quarter 2017 Financial Results and Provide Business Update
Conference Call and Webcast to be Held Wednesday, August 9, 2017, at 4:30 p.m. Eastern Time BEDMINSTER, NJ / ACCESSWIRE / August 4, 2017 / CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company ...
- ACCESSWIRE•3 months ago
CorMedix Inc. Provides Update on Neutrolin(R) Ongoing Phase 3 Clinical Trial Following Favorable FDA Correspondence
BEDMINSTER, NJ / ACCESSWIRE / August 2, 2017 / CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment ...
- Zacks•3 months ago
Implied Volatility Surging For CorMedix Inc (CRMD) Stock Options
CorMedix Inc (CRMD) Stock looks to be lucrative to the option traders on the back of its surging implied volatility.
- Accesswire•3 months ago
CorMedix Inc. Provides Comprehensive Pipeline Update During Research and Development Day
Live Webcast Today, July 12, 2017, beginning at 8:30am ET BEDMINSTER, NJ / ACCESSWIRE / July 12, 2017 / CorMedix Inc. (NYSE MKT: CRMD), a biopharmaceutical company focused on developing and commercializing ...
- Accesswire•4 months ago
CorMedix Inc. Appoints Mehmood Khan, M.D. and Steven Lefkowitz to its Board of Directors
Gary Gelbfish, M.D. Appointed as Observer to the Company's Board of Directors by Elliott Management BEDMINSTER, NJ / ACCESSWIRE / June 26, 2017 / CorMedix Inc. (NYSE MKT: CRMD), a biopharmaceutical company ...
- Zacks•4 months ago
Implied Volatility Surging for CorMedix (CRMD) Stock Options
CorMedix (CRMD) warrants investors' attention based on moves in the options market lately.
- Capital Cube•4 months ago
ETFs with exposure to CorMedix, Inc. : June 16, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to CorMedix, Inc. Here are 5 ETFs with the largest exposure to CRMD-US. Comparing the performance and risk of CorMedix, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)
- Accesswire•4 months ago
CorMedix Inc. to Showcase Its Taurolidine-Based Development Pipeline at Research and Development Day
BEDMINSTER, NJ / ACCESSWIRE / June 14, 2017 / CorMedix Inc. (NYSE MKT: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment ...
